Ernest V. Linek examines the recent arguments and ruling in Bristol-Myers Squibb v. Merck & Co. in Life Sciences Intellectual Property Review
NEWS -Ernest V. Linek discusses Merck’s unsuccessful move to invalidate a Bristol-Myers Squibb patent covering metastatic skin cancer treatment in Life Sciences Intellectual Property Review. In his article, Mr. Linek points out that